Neurocrine Biosciences
NBIX
#1592
Rank
A$18.25 B
Marketcap
A$181.91
Share price
-1.90%
Change (1 day)
5.48%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company